{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:28Z","timestamp":1787772628280,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Background &amp; objectives:<\/jats:italic>\n                      Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a vector borne pathogen, well-known for causing endemic hemorrhagic fever in Asia, Europe and Africa. There is no specific drug or vaccine available against CCHFV. The recent upsurge of Crimean-Congo Hemorrhagic Fever around the globe has made it a major health issue and this demands investigation for specific inhibitors to viral proteins. The objective of this study was to assess inhibitors that may have the potential to dock CCHFV nucleoprotein which plays an important role in viral assembly.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                      We performed structure-based virtual screening and molecular docking by using potent inhibitors against nucleoprotein of CCHFV. Screening was performed by a webserver, MtiOpenScreen which gave 1000 drug-like molecules from PubChem. PyRx Autodock vina was utilized to dock the protein. The docking poses were observed for interaction analysis by LigPlot+. This study provided ten potential candidates capable of binding to the active site of NP of CCHFV. The selected hits were then subjected to toxicity prediction by ProTox-II.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                      Four hits were identified that specifically dock nucleoprotein at the presumed binding site. Furthermore, these compounds have less binding energy i.e., 9.7 kcal\/mol, 9.8 kcal\/mol and 10.4 kcal\/mol and with equal toxicity measures when compared to an FDA approved drug.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Interpretation &amp; conclusion:<\/jats:italic>\n                      This study illustrates that virtual screening is an efficient\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      approach to identify target-specific inhibitors. Researchers in this area who investigate drugs or synthesize agents against CCHFV with better efficacy could utilize reported inhibitors rather than trying random compounds ambivalently.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0972-9062.321757","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:32:31Z","timestamp":1671586351000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A structure-based virtual screening and molecular docking by using potent inhibitors against nucleoprotein of Crimean-Congo hemorrhagic fever virus"],"prefix":"10.4103","volume":"58","author":[{"given":"Hina","family":"Nayab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Asif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehreen","family":"Ul Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyab","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240830","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1099\/vir.0.80121-0","article-title":"Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus","volume":"85","author":"Hewson","year":"2004","journal-title":"Journal of General Virology"},{"key":"R2-5-20240830","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.ijantimicag.2010.06.020","article-title":"Crimean\u2013Congo haemorrhagic fever in Eurasia","volume":"36","author":"Leblebicioglu","year":"2010","journal-title":"International journal of antimicrobial agents"},{"key":"R3-5-20240830","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2017.02.018","article-title":"Current status of Crimean- Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions","volume":"58","author":"Al-Abri","year":"2017","journal-title":"International journal of infectious diseases"},{"key":"R4-5-20240830","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean\u2013Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral research"},{"key":"R5-5-20240830","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1309\/LMN1P2FRZ7BKZSCO","article-title":"Crimean- Congo hemorrhagic fever","volume":"46","author":"Shayan","year":"2015","journal-title":"Laboratory medicine"},{"key":"R6-5-20240830","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1128\/JVI.01627-12","article-title":"Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of cas-pase-3 cleavage","volume":"86","author":"Wang","year":"2012","journal-title":"Journal of virology"},{"key":"R7-5-20240830","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1995-7645.280221","article-title":"Crimean-Congo hemorrhagic fever: etiology, diagnosis, management and potential alternative therapy","volume":"13","author":"Saleem","year":"2020","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"R8-5-20240830","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.gastro.2007.03.035","article-title":"Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy","volume":"132","author":"Lutchman","year":"2007","journal-title":"Gastroenterology"},{"key":"R9-5-20240830","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/infdis\/jiy163","article-title":"Ribavirin had demonstrable effects on the Crimean-Congo hemorrhagic fever virus (CCHFV) population and load in a patient with CCHF infection","volume":"217","author":"Espy","year":"2018","journal-title":"The Journal of Infectious Diseases"},{"key":"R10-5-20240830","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijid.2014.08.015","article-title":"The efficacy of ribavirin in Crimean-Congo hemorrhagic fever-randomized trials are urgently needed","volume":"29","author":"Ceylan","year":"2014","journal-title":"Int J Infect Dis"},{"key":"R11-5-20240830","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser","year":"2010","journal-title":"BMC infectious diseases"},{"key":"R12-5-20240830","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/vbz.2011.0694","article-title":"Re-evaluation of 400 Crimean- Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?","volume":"12","author":"Duygu","year":"2012","journal-title":"Vector-borne and zoonotic Diseases"},{"key":"R13-5-20240830","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clinical infectious diseases"},{"key":"R14-5-20240830","doi-asserted-by":"crossref","first-page":"e23560","DOI":"10.1371\/journal.pone.0023560","article-title":"In vitro and in vivo activity of ribavirin against Andes virus infection","volume":"6","author":"Safronetz","year":"2011","journal-title":"PLoS One"},{"key":"R15-5-20240830","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/bioinformatics\/btt447","article-title":"Protein\u2013ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment","volume":"29","author":"Yang","year":"2013","journal-title":"Bioinformatics"},{"key":"R16-5-20240830","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3797\/scipharm.0803-03","article-title":"Virtual screening: a fast tool for drug design","volume":"76","author":"Vyas","year":"2008","journal-title":"Scientia Pharmaceutica"},{"key":"R17-5-20240830","doi-asserted-by":"crossref","first-page":"W448","DOI":"10.1093\/nar\/gkv306","article-title":"MTiOpenScreen: a web server for structure-based virtual screening","volume":"43","author":"Labb\u00e9","year":"2015","journal-title":"Nucleic acids research"},{"key":"R18-5-20240830","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discovery Today: Technologies"},{"key":"R20-5-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","article-title":"Computer-aided drug design platform using PyMOL","volume":"25","author":"Lill","year":"2011","journal-title":"Journal of computer-aided molecular design"},{"key":"R21-5-20240830","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"Journal of computational chemistry"},{"key":"R23-5-20240830","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic acids research"},{"key":"R24-5-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiolchem.2017.06.003","article-title":"Tetracyclines as a potential antiviral therapy against Crimean Congo hemorrhagic fever virus: Docking and molecular dynamic studies","volume":"70","author":"Sharifi","year":"2017","journal-title":"Computational Biology and Chemistry"},{"key":"R25-5-20240830","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1128\/JVI.01555-12","article-title":"Structure, function, and evolution of the Crimean- Congo hemorrhagic fever virus nucleocapsid protein","volume":"86","author":"Carter","year":"2012","journal-title":"Journal of virology"},{"key":"R26-5-20240830","doi-asserted-by":"crossref","first-page":"243","DOI":"10.6026\/97320630011243","article-title":"Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus","volume":"11","author":"Abazari","year":"2015","journal-title":"Bioinformation"},{"key":"R27-5-20240830","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1073\/pnas.1200808109","article-title":"Crimean\u2013Congo hemorrhagic fever virus nucleoprotein reveals endo-nuclease activity in bunyaviruses","volume":"109","author":"Guo","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.321757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:06:41Z","timestamp":1787771201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.321757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0972-9062.321757","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}